Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine administered concomitantly with other paediatric vaccines in toddlers: a phase III randomised study

Invasive meningococcal disease has high morbidity and mortality, with infants and young children among those at greatest risk. This phase III, open-label, randomised study in toddlers aged 12–23 months evaluated the immunogenicity and safety of meningococcal tetanus toxoid-conjugate vaccine (MenACYW...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhingra, M. S., Namazova-Baranova, L., Arredondo-Garcia, J. L., Kim, K.-H., Limkittikul, K., Jantarabenjakul, W., Perminova, O., Kobashi, I. A. R., Bae, C.-W., Ojeda, J., Park, J., Chansinghakul, D., B'Chir, S., Neveu, D., Bonaparte, M., Jordanov, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080229/
https://www.ncbi.nlm.nih.gov/pubmed/33814028
http://dx.doi.org/10.1017/S0950268821000698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080229/
https://www.ncbi.nlm.nih.gov/pubmed/33814028
http://dx.doi.org/10.1017/S0950268821000698

Ejemplares similares